Ebola - Global Virus Network

Recent Resurgence of Ebola Virus

By vgn1 | October 25, 2021 |

Recent Resurgence of Ebola Virus October 25, 2021 The COVID-19 pandemic negatively impacted the epidemiological control of several infectious diseases worldwide. Specifically, Ebola virus disease has been sporadically resurging in Guinea and the Democratic Republic of the Congo (DRC) in 2021. A total of 16 confirmed and 7 probable cases were reported, of whom 12…

A Summary of Recent Advances in Ebola Treatment

By vgn1 | August 21, 2019 |

August 21, 2019 Only two years ago, neither a vaccine cure for the Ebola Virus, nor effective antivirals existed to prevent Ebola Virus Disease. Recovery for those infected was through the strength of their own immune system, and according to the U.S. Centers of Disease Control and Prevention (CDC), doctors treated patients while keeping them…

Ebola Outbreak in the Democratic Republic of the Congo Shines Light on Global Challenges

By vgn1 | July 24, 2019 |

Last Week the WHO Declared the Epidemic a Public-Health Emergency of International Concern Baltimore, MD, USA, July 24, 2019: Last week, the World Health Organization (WHO) declared the current Ebola outbreak in the Democratic Republic of the Congo (DRC) a public-health emergency of international concern (PHEIC), signaling a risk to multiple countries that requires a…

THE GLOBAL VIRUS NETWORK (GVN) LAUNCHES AFRICA GVN TO JOIN FRENCH AND ENGLISH-SPEAKING SCIENTISTS IN THE FIGHT AGAINST INFECTIOUS DISEASES AND ONGOING EPIDEMICS

By vgn1 | June 25, 2019 |

In the Midst of the Second Worst Ebola Outbreak Since Its Discovery, Top African Scientists Identify Ways to Battle Deadly Diseases Together Baltimore, Maryland, USA, June 25, 2019: During a meeting held last month in Entebbe, Uganda, the Global Virus Network (GVN), representing 48 Centers of Excellence and 7 Affiliates in 29 countries comprising foremost…

GVN Scientist Publishes Ebola – Marburg Virus Connection

By vgn1 | March 2, 2015 |

Dr. Erica Ollmann Saphire’s Lab of The Scripps Research Institute recently published in Cell the discovery of an antibody that binds to both the Marburg and Ebola virus. The ability of an antibody to bind to both of these deadly viruses is a major step forward in the potential treatment of them. Article